Skip to main content
FIREFLY NEUROSCIENCE, INC. logo

FIREFLY NEUROSCIENCE, INC. — Investor Relations & Filings

Ticker · AIFF ISIN · US4566961037 US Professional, scientific and technical activities
Filings indexed 624 across all filing types
Latest filing 2026-05-20 Share Issue/Capital Cha…
Country US United States of America
Listing US AIFF

About FIREFLY NEUROSCIENCE, INC.

https://fireflyneuro.com/

Firefly Neuroscience, Inc. is a medical technology and artificial intelligence company that develops solutions to improve brain health outcomes. The company's flagship product is the FDA-cleared Brain Network Analytics (BNA™) platform, which provides objective, AI-driven assessments for neurological and psychiatric disorders. The BNA™ platform utilizes electroencephalogram (EEG) data, including Event-Related Potentials (ERPs) and spectral analysis, combined with behavioral performance metrics. Using advanced AI, the platform compares a patient's brain activity against an extensive, proprietary, and standardized database of over 17,000 individuals. This process generates a comprehensive, cloud-based report for healthcare professionals, enabling them to make more informed decisions for disease management and personalized treatment plans. The technology serves clinicians and supports CNS drug developers in biomarker discovery and companion diagnostics.

Recent filings

Filing Released Lang Actions
REGISTRATION STATEMENT
Share Issue/Capital Change Classification · 85% confidence The document is a Form S-8 Registration Statement filed with the SEC to register additional shares of common stock under the company’s long-term incentive plan. It is not an earnings release or annual report, but rather a share registration/issuance filing. This fits the ‘Share Issue/Capital Change’ category (SHA).
2026-05-20 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 85% confidence The document is a Form S-3 Registration Statement filed with the U.S. SEC under the Securities Act of 1933, containing a preliminary prospectus for the resale of up to 22,500,000 shares of common stock by selling stockholders. It is a capital markets filing directly related to the company’s financing and capital structure (registering securities for sale) rather than an annual report, management discussion, earnings release, or simple announcement. Therefore, it falls under “Capital/Financing Update (CAP).”
2026-05-20 English
FORM 10-Q
Interim / Quarterly Report Q1 2026
2026-05-13 English
CURRENT REPORT
Share Issue/Capital Change Classification · 85% confidence The document is an SEC Form 8-K (current report) by Firefly Neuroscience, Inc. reporting entry into a material definitive agreement and unregistered sales of equity securities (private placement of common stock and warrants), i.e., a new share issuance and related capital change. This fits the “Share Issue/Capital Change” category (SHA) rather than a pure financing update (CAP) or a general regulatory announcement (RNS).
2026-05-12 English
8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 16, 2026, by Firefly Neuroscience, Inc. It reports the entry into a material definitive agreement related to a securities purchase agreement and an additional closing of a private placement financing. The document details the issuance of units to investors, amendments to lock-up agreements, and related terms. It also includes legal disclaimers about the securities offering and references exhibits such as the amended lock-up agreement. There are no financial statements or comprehensive financial data presented, nor is this a full annual or quarterly report. The content focuses on financing activities and capital raising events. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (8007 characters) and detailed description of the financing transaction support this classification with high confidence.
2026-04-22 English
Regulatory Filings 2026
Regulatory Filings
2026-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.